The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

As per The Business Research Company’s Solid Tumor Testing Global Market Report 2023, The global solid tumor testing market is expected to grow from $23.81 billion in 2022 to $25.74 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The solid tumor testing market is expected to reach $33.91 billion in 2027 at a CAGR of 7.1%.

What was the major driver in the solid tumor testing market?
An increase in the prevalence of cancer is expected to propel the growth of the solid tumor testing market going forward. Cancer is a condition marked by the body’s aberrant cells growing and spreading out of control. These abnormal cells, known as cancer cells, can invade nearby tissues and organs and, in some cases, spread to other parts of the body through the bloodstream or lymphatic system. Most adult cancers are solid tumors, which is about 90%. Solid tumor testing is used to detect cancer cells in the blood of patients with solid tumors, even if the cancer is not yet visible on imaging tests. For instance, in June 2023, according to a report shared by the Centers for Disease Control and Prevention, a US-based national public health agency, there were 1,603,844 new cancer cases and 602,347 cancer-related deaths in the US in 2020, and 403 new cancer cases and 144 cancer-related deaths were reported for every 100,000 people. Therefore, the increasing prevalence of cancer is driving the growth of the solid tumor testing market.

View More On The Solid Tumor Testing Market Report 2023 – https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

What was the key trend in the solid tumor testingmarket?
Innovative liquid biopsy test solutions are a key trend gaining popularity in the solid tumor testing market. Major companies operating in the solid tumor testing market are focused on developing innovative liquid biopsy test solutions to strengthen their position and gain a competitive advantage in the market. For instance, in June 2020, NeoGenomics Inc., a US-based testing laboratory company, launched its comprehensive suite of three solid tumor liquid biopsy tests for cancer patients. These innovative tests are designed to detect cancer cells in the blood of patients with solid tumors, even if the cancer is not yet visible on imaging tests. The tests can be used to help doctors make decisions about further testing or treatment. Additionally, it is non-invasive, has early detection, can be used to personalize treatment, and is FDA-approved. Moreover, these three new tests also have seven days or fewer turnaround times, which can save clinicians considerable time.

Which was the largest region in the solid tumor testing market?
North America was the largest region in the solid tumor testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the solid tumor testingmarketprominent players?
Major players in the solid tumor testing market are Johnson & Johnson Ltd, Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Abbott Molecular Inc., Becton Dickinson And Company (BD), Quest Diagnostics Incorporated, Tosoh Corporation, Agilent Technologies Inc., bioMerieux Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN GmbH, MiltenyiBiotec GmbH, Natera Inc., Myriad Genetics Inc., Novocure Inc., Invitae Corporation, Guardant Health Inc., Foundation Medicine Inc., Epic Sciences Inc., Biocare Medical LLC, Agena Bioscience Inc., Caris Life Sciences Inc., 20/20 Gene Systems Inc., Grail Inc., Avant Diagnostics Inc., Genomic Testing Cooperative, Eutropics Pharmaceuticals Inc., Anixa Biosciences Inc., and Cellular Biomedicine Group.

 Key solid tumor testingmarket segments
The global solid tumor testing market is segmented –
1) By Type: Genetic Testing, Conventional Testing
2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer
3) By Application: Clinical, Research
4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

RequestA Sample Of The Global Solid Tumor Testing Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12658&type=smp

The Solid Tumor Testing Global Market Report 2023 provides a comprehensive overview on the solid tumor testing market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2023
Solid Tumor Cancer Treatment Global Market Report 2023
Tumor Ablation Therapy Devices Global Market Report 2023 

Contact us at:
The Business Research Company:https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn:https://in.linkedin.com/company/the-business-research-company
YouTube:https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model:https://www.thebusinessresearchcompany.com/global-market-model